SCM Pharma appoints Adam Sims

pharmafile | July 5, 2011 | Appointment | Manufacturing and Production, Research and Development |  appointment, manufacturing and production, research and development 

Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive director.

He joins the UK-based contract manufacturing organisation (CMO) with a 20-year track record in the global pharmaceutical and chemical sector.

Prior to joining SCM Adam spent seven years at Aesica in senior commercial and finance roles

He said: “I am looking forward to supporting the executive team with my industry contacts, experience and knowledge to help ensure it continues to maintain its high profile, thrive as an independent business and achieve its commercial objectives.”

The CMO recently picked up a major commercial supply project with Speciality European Pharma (SEP) for its oncology product Plenaxis and a sterile filling project from Italian firm Molteni Therapeutics for a phase II clinical trial.